Pharmacological inhibition of histone deacetylase 6 and DNA damage repair enhances radiosensitivity in melanoma
Cancer Letters · 2026
DOI: 10.1016/j.canlet.2026.218322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Yidian Fu und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Eye Health, Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,…. Hauptthemen laut MEDLINE: Histone Deacetylase 6, Radiation Tolerance, Histone Deacetylase Inhibitors, Melanoma. Die Arbeit nennt 71 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Melanoma, a malignant tumour originating from melanin-producing melanocytes, poses a significant threat to human health, including cutaneous melanoma and uveal melanoma (UM). Although surgical resection remains a primary treatment modality, radiotherapy has emerged as another therapeutic option, particularly for UM. Nevertheless, the adverse effects induced by radiotherapy are considerably pronounced. In this study, we identified WT-161, a selective histone deacetylase 6 (HDAC6) inhibitor, as a potent radiosensitizer for melanoma therapy through high-throughput drug screening. Mechanistically, inhibition of HDAC6 disrupted its interaction with DNA damage repair proteins (DDB2 and DEK) and suppressed gene expression in the DNA damage repair pathway, leading to the accumulation of irradiation-induced DNA damage and tumour regression. Our findings establish HDAC6 as a predictive biomarker for radiation response in melanoma and demonstrate that pharmacological inhibition of HDAC6 with WT-161 could expand the clinical utility of radiotherapy in patients with UM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Eye Health, Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China; Shanghai Key Laboratory of Orbital Diseases and Ocular…
- Shenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, 518040, China.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Science and Technology Commission of Shanghai Municipality
- School of Medicine, Shanghai Jiao Tong University
- Sanming Project of Medicine in Shenzen Municipality
Zitieren
APA
Fu, Y., Jiang, C., Chen, Y., Li, F., He, X., Ma, L., Xie, S., Ye, L., Ge, S., Yu, J., Yang, Z., & Fan, X. (2026). Pharmacological inhibition of histone deacetylase 6 and DNA damage repair enhances radiosensitivity in melanoma. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218322
Vancouver
Fu Y, Jiang C, Chen Y, Li F, He X, Ma L, et al. Pharmacological inhibition of histone deacetylase 6 and DNA damage repair enhances radiosensitivity in melanoma. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218322
BibTeX
@article{Fu2026,
author = {Fu, Yidian and Jiang, Caoyan and Chen, Ying and Li, Fang and He, Xiaoyu and Ma, Liang and Xie, Shuer and Ye, Lin and Ge, Shengfang and Yu, Jie and Yang, Zhi and Fan, Xianqun},
title = {Pharmacological inhibition of histone deacetylase 6 and DNA damage repair enhances radiosensitivity in melanoma},
journal = {Cancer Letters},
year = {2026},
doi = {10.1016/j.canlet.2026.218322}
}
EUVIMED